Goosehead Insurance (GSHD) will replace NuVasive(NUVA) in the S&P SmallCap 600. S&P MidCap 400 constituent Globus Medical (GMED) is acquiring NuVasive in a deal expected to close soon pending final conditions.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on GSHD:
- Goosehead Insurance Introduces an Agency Launch Program to Champion Aspiring Entrepreneurs
- Goosehead Insurance price target raised to $86 from $60.54 at BMO Capital
- Goosehead Insurance price target raised to $80 from $72 at RBC Capital
- Goosehead Insurance price target raised to $76 from $64 at Piper Sandler
- Goosehead Insurance, Inc. Announces Second Quarter 2023 Results